This HTML5 document contains 37 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n10http://linked.opendata.cz/resource/drugbank/drug/DB04759/identifier/pdb/
n9http://linked.opendata.cz/resource/drugbank/drug/DB04759/identifier/bindingdb/
n11http://linked.opendata.cz/resource/drugbank/drug/DB04759/identifier/pubchem-compound/
n15http://linked.opendata.cz/resource/drugbank/drug/DB04759/identifier/pubchem-substance/
n14http://linked.opendata.cz/resource/drugbank/drug/DB04759/identifier/drugbank/
n4http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n7http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n13http://linked.opendata.cz/resource/drugbank/drug/DB04759/identifier/chemspider/
n5http://linked.opendata.cz/ontology/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB04759
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n4:DB04759 n7:DB04759
dcterms:title
PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(3-METHYL-BENZYLAMIDE)
adms:identifier
n9:16595 n10:PB3 n11:5289109 n13:4451138 n14:DB04759 n15:46508426
n5:IUPAC-Name
n6:271B50AE-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B50B4-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B50B3-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B50B0-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B50B1-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B50B2-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B50AC-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B50AA-363D-11E5-9242-09173F13E4C5 n6:271B50AD-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B50AB-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B50BA-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B50BB-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B50B5-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B50B6-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B50B8-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B50B7-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B50B9-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B50C0-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B50C2-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B50C3-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B50BF-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B50BE-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B50C1-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B50AF-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B50BC-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B50BD-363D-11E5-9242-09173F13E4C5